Eiger Biopharmaceuticals Inc buy Reibach111
Start price
23.07.17
/
50%
€8.79
Target price
11.01.18
€13.53
Performance (%)
53.85%
End price
11.01.18
€13.53
Summary
This prediction ended on 11.01.18 with a price of €13.53. The BUY prediction by Reibach111 for Eiger Biopharmaceuticals Inc saw massive gains of 53.85%. Reibach111 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Eiger Biopharmaceuticals Inc | - | - | - | - |
| iShares Core DAX® | -1,74 % | 5,98 % | 8,98 % | 49,86 % |
| iShares Nasdaq 100 | 2,81 % | 11,83 % | 38,41 % | 100,33 % |
| iShares Nikkei 225® | -0,11 % | 11,69 % | 46,68 % | 65,35 % |
| iShares S&P 500 | 0,97 % | 7,62 % | 28,14 % | 68,66 % |
Comments by Reibach111 for this prediction
In the thread Eiger Biopharmaceuticals Inc diskutieren
Reibach111 stimmt dem Crowdsentiment von 'Buy' zu
Reibach111 stimmt am 23.07.2017 dem Buy-Crowdsentiment mit dem Kursziel 13.3$ zu.
(Zielkurs erreicht)


